NeuBase Therapeutics Inc Watch

from 8-K 40 pages NeuBase Therapeutics, Inc., a Delaware Corporation (The “Company”), Proposes, Subject to the Terms and Conditions Stated Herein, to Issue and Sell From Time to Time Through Jefferies LLC, as Sales Agent and/or Principal (The “Agent”), Shares of the Company’s Common Stock, Par Value $0.0001 Per Share (The “Common Shares”), Having an Aggregate Offering Price of Up to $50,000,000 on the Terms Set Forth in This Agreement (This “Agreement”). Section 1. Definitions (A) Certain Definitions. for Purposes of This Agreement, Capitalized Terms Used Herein and Not Otherwise Defined Shall Have the Following Respective Meanings

from 8-K 46 pages NeuBase Therapeutics, Inc. 8,000,000 Shares Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement

from 8-K 42 pages NeuBase Therapeutics, Inc. (A Delaware Corporation) 5,250,000 Shares of Common Stock Underwriting Agreement

from 8-K 34 pages 3,703,704 Shares Ohr Pharmaceutical, Inc. Common Stock Underwriting Agreement

from SC 13G 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Rule 13d-1